Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
01 Mar 2016 EMA Recommends Extending Indications for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
29 Feb 2016 EMA Recommends Extending Indications for Afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Feb 2016 EMA Recommends Extending the Use of Nivolumab Genitourinary cancers - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
25 Feb 2016 US FDA Seeks Support for the National Cancer Moonshot Initiative Bioethics, legal and economic issues
24 Feb 2016 US NCI to Overhaul NCI-60 Tumour Cell Lines Translational research
23 Feb 2016 NICE UK Recommends Nivolumab for Treatment of Advanced Melanoma in Adults Melanoma - Cancer Immunology and Immunotherapy
22 Feb 2016 The EurOPDX Consortium Translational research
18 Feb 2016 Acquired Resistance to Immunotherapy Cancer Immunology and Immunotherapy
17 Feb 2016 Investing in the US National Cancer Moonshot Bioethics, legal and economic issues
15 Feb 2016 How to Facilitate Development of Cancer Immunotherapies Bioethics, legal and economic issues - Cancer Immunology and Immunotherapy
15 Feb 2016 FDA Grants Breakthrough Therapy Designation for Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma Sarcomas - Cancer Immunology and Immunotherapy
11 Feb 2016 FDA Grants Breakthrough Therapy Designation for Sacituzumab Govitecan for the Treatment of TNBC Breast cancer - Cancer Immunology and Immunotherapy
10 Feb 2016 Academic Research in Breast Cancer Breast cancer
08 Feb 2016 Exploring the Growing Interest in Drug Repurposing in Oncology Bioethics, legal and economic issues
04 Feb 2016 ESMO Press Release: World Cancer Day 2016 – ESMO and Patient Advocates, Together to Support Research Bioethics, legal and economic issues